Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Staley

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
The American Journal of Psychiatry|July 10, 2012
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorderAybala Saricicek, Irina Esterlis, Kathleen H Maloney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CAR T-Cell Therapy for Liver CancerHong Liu, Yiyang Xu, Jingyi Xiang, et al.
Cancer Discovery|October 20, 2023
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate CancerOlivier Nolan-Stevaux, Cong Li, Lingming Liang, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
The American Journal of Psychiatry|July 10, 2012
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorderAybala Saricicek, Irina Esterlis, Kathleen H Maloney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CAR T-Cell Therapy for Liver CancerHong Liu, Yiyang Xu, Jingyi Xiang, et al.
Cancer Discovery|October 20, 2023
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate CancerOlivier Nolan-Stevaux, Cong Li, Lingming Liang, et al.
Pageof 10